Stay updated on VIP152 Dose Escalation Study in Advanced Cancer Clinical Trial
Sign up to get notified when there's something new on the VIP152 Dose Escalation Study in Advanced Cancer Clinical Trial page.

Latest updates to the VIP152 Dose Escalation Study in Advanced Cancer Clinical Trial page
- CheckyesterdayChange DetectedAdded the keyword 'Cutaneous neuroendocrine carcinoma' to the study's keywords/MeSH terms.SummaryDifference0.0%

- Check8 days agoChange DetectedHepatocellular carcinoma keyword/MeSH term was added, and the page revision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3 in the page footer.SummaryDifference0.0%

- Check44 days agoChange DetectedGastric cancer keyword added; site revision updated from v3.4.1 to v3.4.2.SummaryDifference0.1%

- Check51 days agoChange DetectedThe page shows a minor version update from Revision: v3.4.0 to Revision: v3.4.1 in the footer, with no changes to trial information or user workflows. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check73 days agoChange DetectedRevision changed from v3.3.3 to v3.3.4 on the page, indicating a minor site version update; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to VIP152 Dose Escalation Study in Advanced Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the VIP152 Dose Escalation Study in Advanced Cancer Clinical Trial page.